Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral (Z)-endoxifen dose-response study in premenopausal women with measurable breast density
2020-004828-42Phase 2Active
- Sponsor
- Atossa Therapeutics
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing (Z)-endoxifen with Placebo (2 arms). Primary endpoint: Change of mammographic density area. Started Oct 2020; status: active.
02
Drugs
z-endoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2020-004828-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004828-42.